MedPath

'An excellent outcome': TAVR safe and effective for patients in their nineties

New data in *The American Journal of Cardiology* shows TAVR is safe and effective for nonagenarians, with a 30-day mortality rate of 5.5% and 1-year mortality of 11.6%, suggesting fast recovery post-TAVR.


Reference News

'An excellent outcome': TAVR safe and effective for patients in their nineties

New data in *The American Journal of Cardiology* shows TAVR is safe and effective for nonagenarians, with a 30-day mortality rate of 5.5% and 1-year mortality of 11.6%, suggesting fast recovery post-TAVR.

© Copyright 2025. All Rights Reserved by MedPath